Brief: Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement

Amylyx Pharmaceuticals

21/06/2024 21:36

June 21 (Reuters) - Eiger Biopharmaceuticals Inc:
    * COMPANY AND AMYLYX ENTERED INTO AN ASSET PURCHASE
AGREEMENT
    * AMYLYX AGREED TO BUY ALL OF CO'S RIGHTS, TITLE,INTERESTS
IN
ASSETS,INTERESTS USED IN DEVELOPMENT,
MANUFACTURE,COMMERCIALIZATION OF AVEXITIDE
    * ASSET PURCHASE AGREEMENT FOR $35.1 MILLION, PLUS AGGREGATE
AMOUNT OF DETERMINED CURE COSTS AND ASSUMED LIABILITIES


 ((Reuters.Briefs@thomsonreuters.com;))